Infleqtion | $100,000,000 | (Jun 3, 2025)
Literal Labs | $6,223,938 | (Jun 3, 2025)
LuminX | $5,500,000 | (Jun 3, 2025)
Certified by Founder
Lodge
T-Therapeutics Ltd
start up
United Kingdom
- Cambridge
- 16/11/2023
- Series A
- $59,707,000
T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanized TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs.
We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
- Industry Biotechnology Research
- Website https://t-therapeutics.com/
- LinkedIn https://www.linkedin.com/company/t-therapeutics/about/
Limited | $7,000,000 | (Jun 3, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
KhiladiPro | $1,000,000 | (May 30, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
CurifyLabs | $7,594,115 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)
Unbound(US) | $4,000,000 | (May 30, 2025)